Article
NAT2 slow acetylation haplotypes are associated with the increased risk of betel quid-related oral and pharyngeal squamous cell carcinoma.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics - 1 Oct 2011
Hou Yu-Yi, Ou Hui-Ling, Chu Sau-Tung, Wu Pi-Chuang, Lu Pei-Jung, Chi Chao-Chuan, Leung Kam-Wing, Lee Chien-Yiing, Wu Pi-Hsiung, Hsiao Michael, Ger Luo-Ping
Abstract excerpt
BACKGROUND: NAT2, the most important phase II metabolic enzyme for betel quid (BQ), might modify the risk of BQ-related oral and pharyngeal squamous cell carcinoma (OPSCC) in Taiwan. STUDY DESIGN: PCR-RFLP and TaqMan assay were conducted for genotyping of NAT2 in 172 OPSCC cases and 170 healthy controls who habitually chewed BQ. RESULTS: The genotypic and allelic type of T341C and C481T in NAT2 are associated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
